1. Evans, M. E., Walker, S. R., Brittain, R. T., Paterson, J. W.: The metabolism of salbutamol in man. Xenobiotica3, 113?120 (1973)
2. Gamissans, O., Esteban-Altiribba, J., Maiques, V.: Inhibition of human myometrial activity by a new ?-adrenergic drug (DU 21220). J. Obstet. Gynaecol. Br. Commonw.76, 656 (1969)
3. Kilsdonk, A. C. M.: Non-linear optimisation package OPTPAC3, program description and reference manual. Philips Gloeilampenfabrieken N. V., Eindhoven, the Netherlands, Publication no. UDV-SCA/SCA/TK/045/ap (1977)
4. Kleinhout, J., Veth, A. F. L.: Placental transfer of ritodrine and its effect on the fetal cardiovascular system. In: Aspects of obstetrics today. T. K. A. B. Eskes et al. (eds.), pp. 385?390. Amsterdam: Elsevier 1975
5. Leferink, J. G., Wagemaker-Engels, I., Maas, R. A. A., Lamont, H., Pauwels, R., Van der Straaten, M.: Quantitative analysis of terbutaline in serum and urine at therapeutic levels using gas chromatography ? mass spectrometry. J. Chromatogr.143, 299?305 (1977)